We are live on ! Find out more
CCRN

Cross Country Healthcare

Delisted

CCRN was delisted on the 20th of July, 2026.

174 hedge funds and large institutions have $835M invested in Cross Country Healthcare in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 63 increasing their positions, 70 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

605% more call options, than puts

Call options by funds: $860K | Put options by funds: $122K

1.16% more ownership

Funds ownership: 103.73%104.89% (+1.2%)

7% less funds holding

Funds holding: 188174 (-14)

9% less capital invested

Capital invested by funds: $921M → $835M (-$85.9M)

10% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 70

43% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 28

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
174
Holders Change
-14
Holders Change %
-7.45%
% of All Funds
2.53%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
16
Increased
63
Reduced
70
Closed
28
Calls
$860K
Puts
$122K
Net Calls
+$738K
Net Calls Change
-$2.77M

CCRN Hedge Fund Activity: Q4 2023 in Review

174 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Cross Country Healthcare (CCRN) for Q4 2023, worth a combined $835M — down 9.3% from $921M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of CCRN and 16 opened new positions — a net loss of 12 holders — while 70 trimmed existing stakes and 63 added.

The largest buyer was Wasatch Advisors, adding an estimated $20.3M. The largest seller was Morgan Stanley, cutting an estimated $10.6M.

  • 174 institutional investors held Cross Country Healthcare (CCRN) as of Q4 2023, down from 188 in Q3 2023.
  • Funds reported $835M of Cross Country Healthcare stock for Q4 2023, down 9.3% quarter-over-quarter.
  • 16 funds opened new Cross Country Healthcare positions in Q4 2023 and 28 closed out, a net change of -12 holders.
  • The largest Cross Country Healthcare buyer in Q4 2023 was Wasatch Advisors, an estimated $20.3M added.
  • The largest Cross Country Healthcare seller in Q4 2023 was Morgan Stanley, an estimated $10.6M sold.

Based on aggregated 13F filings for Q4 2023.